License procedures concerning manufacture of OTCs eased

Published: 2003-05-23 07:00:00

Updated: 2003-05-23 07:00:00

The Korea Food and Drug Administration announced recently that a series of measures designed to expand the number of OTC products will be adopted via drug-related reforms including re-evaluation of drugs.

The KFDA said that the measures are part of the government's efforts to boost the manufac...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK